Clinical trial

Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

NCT04189848

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Semaglutide Normalized identity: semaglutideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Dulaglutide Normalized identity: dulaglutideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-12-03

PhasePHASE4

Conditions

Healthy Volunteersunresolved

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Overweightunresolved

Obesityverified · MONDO: obesity disorder

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

DulaglutideDRUG · verified · RxNorm: dulaglutide

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04189848 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.